SUN PHARMA ADVANCED RESEARCH Q2 FY27 ; NET LOSS AT ₹24 CR VS LOSS ₹76 CR (YOY), LOSS ₹21 CR (QOQ)

REVENUE UP 282% AT ₹30 CR (YOY), DOWN 25% (QOQ) EBITDA LOSS AT ₹46 CR VS LOSS ₹66 CR (YOY), LOSS ₹34 CR (QOQ) MARGINS AT -151.9% VS -836.1% (YOY), -85.2% (QOQ)

SUN PHARMA ADV.RES.CO.LTD

← Back to feed